Back to results
US 2024/0392035 A1Published application
Engineered anti-her2 bispecific proteins
AssigneeDenali Therapeutics Inc.
InventorsAbira BANDYOPADHYAY, Allisa Jayne CLEMENS, Do Jin KIM, Michelle E. PIZZO, Lu SHAN, Richard THÉOLIS, Jr., Raymond Ka Hang TONG
Life of this patent
Estimating the term…
Abstract
In one aspect, bispecific proteins having the ability to specifically bind to both subdomain II of human HER2 and subdomain IV of human HER2 are provided. In another aspect, methods of treating a cancer or treating brain metastasis of a cancer using a bispecific protein that specifically binds to subdomain II and subdomain IV of human HER2 are provided.
Claims78
A protein comprising:
- (a) a first Fc polypeptide that is fused at the N-terminus to an Fd portion of a Fab;
- (b) a second Fc polypeptide that is fused at the N-terminus to a single-chain variable fragment (scFv), wherein the first and second Fc polypeptides form an Fc dimer;
- and
- (c) a light chain polypeptide that pairs with the Fd portion recited in (a) to form a Fab,
- wherein the Fab binds to subdomain II of human HER2 and the scFv binds to subdomain IV of human HER2, or wherein the Fab binds to subdomain IV of human HER2 and the scFv binds to subdomain II of human HER2, and
- wherein the first Fc polypeptide and/or the second Fc polypeptide independently comprises a S239D and/or a I332E substitution, according to EU numbering.
3 more elements
A protein comprising:
- (a) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:1, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:159, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (b) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 164, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:173, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (c) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 164, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:174, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (d) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 166, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:173, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (e) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 165, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:173, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (f) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 165, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:174, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (g) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 167, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:173, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (h) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 164, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:175, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (i) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 164, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:176, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (j) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 166, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:175, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (k) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 165, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:175, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (l) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 165, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:176, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25;
- or
- (m) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 167, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:175, and (iii) a light chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:25.
34 more elements
A protein comprising:
- (a) a first Fc polypeptide that is fused at the N-terminus to an Fd portion of a Fab;
- (b) a second Fc polypeptide that is fused at the N-terminus to an Fd portion of a Fab, wherein the first and second Fc polypeptides form an Fc dimer;
- and
- (c) two light chain polypeptides that each pairs with each Fd portion recited in (a) and (b) to form a Fab,
- wherein the Fd portion in (a) and/or (b) is fused at the N-terminus to an scFv,
- wherein the Fab binds to subdomain II of human HER2 and the scFv binds to subdomain IV of human HER2, or wherein the Fab binds to subdomain IV of human HER2 and the scFv binds to subdomain II of human HER2, and
- wherein the first Fc polypeptide and/or the second Fc polypeptide independently comprises a S239D and/or a I332E substitution, according to EU numbering.
4 more elements
A protein comprising:
- (a) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:6, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:160, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (b) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:6, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:161, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (c) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:6, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:162, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (d) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:177, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (e) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:178, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (f) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 171, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:177, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (g) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:177, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (h) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:178, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (i) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 172, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:177, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (j) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:179, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (k) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:180, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (l) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 171, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:179, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (m) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:179, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (n) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:180, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (o) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 172, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:179, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (p) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:181, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (q) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 169, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:182, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (r) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 171, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:181, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (s) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:181, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (t) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 170, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:182, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26;
- or
- (u) (i) a first heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:
- 172, (ii) a second heavy chain polypeptide comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:181, and (iii) two light chain polypeptides each comprising a sequence having at least 90% identity to the sequence of SEQ ID NO:26.
56 more elements
Dependencies are inferred from the claim text.